BTG3 and adenocarcinoma: According to Kaplan-Meier plotter, we found that a higher BTG3 expression was negatively correlated with overall survival rates of all cancer patients, female or male patients, adenocarcinoma patients, N1, M0, Stage I and II cancer patients, smoking and non-smoking patients, or those with surgical margin negative (Figure 2F, p < 0.05).